{"abstract":"The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to New York Blood Center, Inc. (``NYBC''), located in New York, New York, in its rights to the technologies and patent applications listed in the Supplementary Information section of this notice.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2021/07/01/2021-14128.html","cfr_references":[],"citation":"86 FR 35101","comment_url":null,"comments_close_on":"2021-07-16","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases, on or before July 16, 2021 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2021-14128","effective_on":null,"end_page":35102,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2021/07/01/2021-14128.xml","html_url":"https://www.federalregister.gov/documents/2021/07/01/2021-14128/prospective-grant-of-exclusive-license-inter-institutional-agreement-institution-lead-biomarkers-and","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2021-14128?publication_date=2021-07-01","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2021-07-01/2021-14128/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":115,"last_updated":"2026-06-24 08:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-07-01/pdf/2021-14128.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-14128.pdf?1625057145","publication_date":"2021-07-01","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2021/07/01/2021-14128.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T22:31:15Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":35101,"subtype":null,"title":"Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Biomarkers and Immunogenic Compositions for Filarial Parasites","toc_doc":"Inter-Institutional Agreement-Institution Lead; Biomarkers and Immunogenic Compositions for Filarial Parasites","toc_subject":"Prospective Grant of Exclusive License:\n","topics":[],"type":"Notice","volume":86}